Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

BACKGROUND: The aim of this study was to evaluate the usefulness of the presence of malignant pleural effusion (MPE) as a negative predictor of anti‐PD‐1 antibody efficacy. METHODS: A retrospective review of patients with advanced or recurrent non‐small cell lung cancer treated with an anti‐PD‐1 ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibaki, Ryota, Murakami, Shuji, Shinno, Yuki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Motoi, Noriko, Yamamoto, Noboru, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449236/
https://www.ncbi.nlm.nih.gov/pubmed/30762312
http://dx.doi.org/10.1111/1759-7714.13004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449236/
https://www.ncbi.nlm.nih.gov/pubmed/30762312
http://dx.doi.org/10.1111/1759-7714.13004

Ejemplares similares